MiNA’s gene-activating tech wins an AstraZeneca alliance
Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome
Vertex looks beyond cystic fibrosis with $950m Semma buy
Funds will go towards development of AMRA’s body composition profiling tool AMRA Profiler.
Pfizer, Novo invest in Swedish patient stratification startup